Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.
from Latest Science News -- ScienceDaily https://ift.tt/2T0vgnF
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment